# Silo Pharma, Inc.: filings

SILO · Nasdaq · CIK 1514183 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/silo.md) · [Financials](/companies/silo/financials.md) · [Filings](/companies/silo/filings.md) · [Insiders](/companies/silo/insiders.md)

## Reports and events: 182 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 88, 10-Q 46, 4 39, 10-K 15, CORRESP 15, 3 14, EFFECT 13, 424B3 11, S-1/A 11, D 10, UPLOAD 10, DEF 14A 8, S-1 8, SC 13G 8, DEFA14A 7, SCHEDULE 13G/A 7, PRE 14A 6, SC 13G/A 6, 40-17G 5, SCHEDULE 13G 5, 424B5 4, NT 10-Q 4, 4/A 3, 8-K/A 3, ARS 3, POS AM 3, 3/A 2, 424B4 2, DEF 14C 2, NT 10-K 2, PRE 14C 2, S-3 2, SC 13D 2, 10-K/A 1, 8-A12B 1, 8-A12G 1, 8-K12B 1, CERT 1, D/A 1, DEFR14A 1, DRS 1, N-54A 1, N-54C 1, S-3/A 1, S-8 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 20:30 ET | [8-K](/filings/0001213900-26-109457.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-109457 |
| 2026-10-02 | 20:37 ET | [8-K](/filings/0001213900-26-106435.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-106435 |
| 2026-08-19 | 21:17 ET | [8-K](/filings/0001213900-26-091783.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-091783 |
| 2026-08-17 | 20:05 ET | [8-K](/filings/0001213900-26-090748.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-090748 |
| 2026-08-13 | 20:06 ET | [10-Q](/filings/0001213900-26-089085.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089085 |
| 2026-07-13 | 22:29 ET | [8-K](/filings/0001213900-26-077296.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-077296 |
| 2026-06-30 | 11:06 ET | [DEF 14A](/filings/0001213900-26-073367.md) | Proxy statement, period 2026-08-14 | 0001213900-26-073367 |
| 2026-06-18 | 21:15 ET | [8-K](/filings/0001213900-26-070212.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-070212 |
| 2026-06-03 | 21:00 ET | [8-K](/filings/0001213900-26-064804.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-064804 |
| 2026-06-01 | 13:02 ET | [8-K](/filings/0001213900-26-063185.md) | 8.01 Other events | 0001213900-26-063185 |
| 2026-05-14 | 23:54 ET | [10-Q](/filings/0001213900-26-056079.md) | Quarterly report, period 2026-03-31 | 0001213900-26-056079 |
| 2026-04-02 | 20:15 ET | [8-K](/filings/0001213900-26-039352.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-039352 |
| 2026-03-27 | 20:40 ET | [10-K](/filings/0001213900-26-035576.md) | Annual report, period 2025-12-31 | 0001213900-26-035576 |
| 2026-02-23 | 22:00 ET | [8-K](/filings/0001213900-26-019384.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-019384 |
| 2025-12-29 | 14:04 ET | [8-K](/filings/0001213900-25-125838.md) | 3.01 Delisting notice | 0001213900-25-125838 |
| 2025-11-13 | 21:18 ET | [10-Q](/filings/0001213900-25-110006.md) | Quarterly report, period 2025-09-30 | 0001213900-25-110006 |
| 2025-10-29 | 22:32 ET | [S-1](/filings/0001213900-25-103188.md) | Registration statement | 0001213900-25-103188 |
| 2025-10-24 | 20:39 ET | [8-K](/filings/0001213900-25-102222.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-102222 |
| 2025-10-01 | 20:30 ET | [8-K](/filings/0001213900-25-094711.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-094711 |
| 2025-09-05 | 21:05 ET | [DEF 14A](/filings/0001213900-25-085119.md) | Proxy statement, period 2025-10-24 | 0001213900-25-085119 |
| 2025-08-13 | 20:16 ET | [10-Q](/filings/0001213900-25-075693.md) | Quarterly report, period 2025-06-30 | 0001213900-25-075693 |
| 2025-08-05 | 20:01 ET | [8-K](/filings/0001213900-25-072062.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-072062 |
| 2025-07-29 | 20:32 ET | [8-K](/filings/0001213900-25-068740.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-068740 |
| 2025-07-10 | 20:30 ET | [8-K](/filings/0001213900-25-062805.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-062805 |
| 2025-07-03 | 20:45 ET | [8-K](/filings/0001213900-25-061531.md) | 3.01 Delisting notice | 0001213900-25-061531 |
| 2025-05-16 | 20:30 ET | [8-K](/filings/0001213900-25-044913.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-044913 |
| 2025-05-09 | 20:32 ET | [S-1/A](/filings/0001213900-25-041563.md) | Registration statement, amended | 0001213900-25-041563 |
| 2025-05-09 | 20:06 ET | [10-Q](/filings/0001213900-25-041519.md) | Quarterly report, period 2025-03-31 | 0001213900-25-041519 |
| 2025-04-29 | 11:39 ET | [S-1/A](/filings/0001213900-25-036374.md) | Registration statement, amended | 0001213900-25-036374 |
| 2025-04-25 | 21:10 ET | [S-1](/filings/0001213900-25-035652.md) | Registration statement | 0001213900-25-035652 |
| 2025-03-28 | 20:28 ET | [10-K](/filings/0001013762-25-004139.md) | Annual report, period 2024-12-31 | 0001013762-25-004139 |
| 2025-03-10 | 11:31 ET | [8-K](/filings/0001213900-25-021916.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-021916 |
| 2025-03-07 | 12:00 ET | [8-K](/filings/0001213900-25-021345.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-021345 |
| 2025-01-02 | 16:11 ET | [8-K](/filings/0001213900-25-000191.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-000191 |
| 2024-12-20 | 22:00 ET | [8-K](/filings/0001213900-24-111256.md) | 5.07 Shareholder vote results | 0001213900-24-111256 |
| 2024-11-12 | 21:42 ET | [10-Q](/filings/0001213900-24-096841.md) | Quarterly report, period 2024-09-30 | 0001213900-24-096841 |
| 2024-11-08 | 21:03 ET | [8-K](/filings/0001213900-24-095886.md) | 8.01 Other events | 0001213900-24-095886 |
| 2024-09-18 | 20:15 ET | [DEF 14A](/filings/0001213900-24-079883.md) | Proxy statement, period 2024-11-12 | 0001213900-24-079883 |
| 2024-09-10 | 10:46 ET | [8-K](/filings/0001213900-24-077111.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-077111 |
| 2024-08-21 | 21:20 ET | [S-1](/filings/0001213900-24-071525.md) | Registration statement | 0001213900-24-071525 |
| 2024-08-13 | 20:30 ET | [10-Q](/filings/0001213900-24-068296.md) | Quarterly report, period 2024-06-30 | 0001213900-24-068296 |
| 2024-07-25 | 20:30 ET | [S-1/A](/filings/0001013762-24-001151.md) | Registration statement, amended | 0001013762-24-001151 |
| 2024-07-22 | 21:00 ET | [8-K](/filings/0001013762-24-000518.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001013762-24-000518 |
| 2024-07-17 | 20:45 ET | [S-1](/filings/0001213900-24-062184.md) | Registration statement | 0001213900-24-062184 |
| 2024-07-08 | 20:15 ET | [8-K](/filings/0001213900-24-059821.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-059821 |
| 2024-06-27 | 20:23 ET | [8-K](/filings/0001213900-24-056678.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-056678 |
| 2024-06-06 | 20:52 ET | [8-K](/filings/0001213900-24-050405.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-050405 |
| 2024-06-04 | 20:05 ET | [8-K](/filings/0001213900-24-049658.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-049658 |
| 2024-05-13 | 20:05 ET | [10-Q](/filings/0001213900-24-042299.md) | Quarterly report, period 2024-03-31 | 0001213900-24-042299 |
| 2024-04-05 | 20:01 ET | [8-K](/filings/0001213900-24-030805.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-030805 |

Page 1 of 4. [Older](/companies/silo/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.